Showing results (161-170 of 254) with videos related to

Sort By:
Pageof 26
Transplantation|February 24, 2007
Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cellsKirsten E Herbert, Carl R Walkley, Ingrid G Winkler, et al.
Internal Medicine Journal|October 20, 2021
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceGreg Hapgood, Maya Latimer, Sze Ting Lee, et al.
The Australasian Journal of Dermatology|July 12, 2018
Psoriasis and cancer. An Australian/New Zealand narrativeMarius Rademaker, Diana M Rubel, Karen Agnew, et al.
Leukemia & Lymphoma|July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantSimon J Harrison, Andy K Hsu, Paul Neeson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trialMadeleine Duvic, Reinhard Dummer, Jürgen C Becker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2017
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancersDevesh Oberoi, Victoria M White, John F Seymour, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
International Journal of Cancer|May 14, 2026
Early-Life Exposures and Risk of Multiple Myeloma: A Population-Based Case-Control Study in AustraliaZhuoyu Sun, Julie K Bassett, Simon Cheah, et al.
Palliative & Supportive Care|October 10, 2019
A feasibility and acceptability study of an adaptation of the Mindful Self-Compassion program for adult cancer patientsJoanne Brooker, John Julian, Jeremy Millar, et al.
Biomarker Research|October 4, 2014
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphomaFrancine Foss, Bertrand Coiffier, Steven Horwitz, et al.
Pageof 26